Prevention of venous thrombosis after total knee arthroplasty. Comparison of antithrombin III and low-dose heparin with dextran.
In a prospective, randomized trial, we compared the efficacy of a combination of antithrombin III and heparin with that of dextran 40 as prophylaxis against venous thrombosis after total knee arthroplasty. Ascending venography identified thrombosis in about one-third of the patients who received the combination of antithrombin III and heparin, compared with about four-fifths of those who received dextran (p less than 0.001). In both groups, the patients who had venous thrombosis had a significantly lower concentration of antithrombin III postoperatively than those who did not have thrombosis. Venous thrombosis occurred in all patients in whom the concentration of antithrombin III was less than 65 per cent postoperatively. These findings demonstrated that, after total knee replacement, the combination of antithrombin III and heparin effectively reduces the incidence of postoperative venous thrombosis and is significantly better than dextran. Furthermore, the findings suggested a relationship between postoperative deficiency of antithrombin III and the occurrence of thrombotic complications.
University of Rochester Medical Center, New York 14642.
C W
CW
Francis
V D
VD
Pellegrini
B N
BN
Stulberg
M L
ML
Miller
S
S
Totterman
V J
VJ
Marder
D000328:Adult; D000990:Antithrombin III / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D003911:Dextrans / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006400:Hematocrit; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007720:Knee Prosthesis / Q000009:adverse effects*; D008297:Male; D010690:Phlebography; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D013924:Thrombophlebitis / Q000209:etiology / Q000517:prevention & control*
D003911:Dextrans; D000990:Antithrombin III; D006493:Heparin